Sigler VAA, Duarte VA, Delgado MR, Sigler MJG

Language: Spanish
References: 11
Page: 1-11
PDF size: 337.62 Kb.

ABSTRACT

The presence of necrotizing scleritis is rare; it needs a diagnosis and an opportune treatment, since its course is fast, severe and destructive of the integrity of the eyeball. We present a 43-year-old patient who required ophthalmological attention when presenting the red right eye with intense pain. Three nodules were found in the antero-inferior scleral region. Fine needle aspiration was performed on the scleral nodules and a fragment of one of them was obtained for the histological section. In both samples, inflammatory infiltrate of lymphocytes and neutrophils with some plasma cells was observed. He was prescribed treatment with oral prednisone (0.5 mg /kg/day), prednisolone eye drops and azathioprine at a dose of 1.5 mg/kg/day. The evolution to the month was satisfactory with gradual improvement of the lesions. The treatment was maintained for 3 months with repeated blood tests. Drug doses were subsequently reduced until their elimination at 6 months. The healing of the injuries was total. No systemic disease was found during the clinical check-up.

REFERENCES

1. Watson P, Romano A. The impact of new methods of investigation and treatment on the understanding of the pathology of scleral inflammation. Eye. 2014 [acceso: 23/07/2018];28:915-30. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4135249/

2. Watson PG. Hayreh SS, Awdry PN. Episcleritis and scleritis. Brit Ophthalmol. 1968;52(3):278-9.

3. Watson PG, Young RD. Scleral structure, organization and disease. Exp Eye Res. 2004 [acceso: 23/06/2018];78(3):609-23. Disponible en: https://www.sciencedirect.com/ science/article/pii/S0014483503002124

4. Wieringa WG, Wieringa JE, Ten Dam-van Loon NH, Los LI. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmol. 2013 [acceso: 02/07/2018];120(2):379-86. Disponible en: https://www.sciencedirect.com /science/article/pii/S0161642012007609

5. Wakefield D, Di Girolamo N, Thurau S, Wildner G, McCluskey P. Scleritis: immunopathogenesis and molecular basis for therapy. Prog Retin Eye Res. 2013 [acceso: 04/07/2018];35:44-62. Disponible en: https://www.sciencedirect.com/science/article/pii/ S0161642012007609#aep-abstract-sec-id12

6. Cuchacovich M, Pacheco P, Díaz G, Rojas B, Stoppel J, Merino G, Verdaguer JI, Verdaguer J, Villarroel F. Role of Azathioprine in steroid resistant non-infectious ocular inflammatory diseases. Rev Med Chil. 2007 [acceso: 23/06/2018];135(6):702-7. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872007 000600003&lng=en&nrm=iso&tlng=en

7. Heiligenhaus A, Schilling M, Lung E, Steuhl KP. Ultrasound biomicroscopy in scleritis. Ophthalmology. 1998;105(3):527-34.

8. Zur D, Neudorfer M, Shulman S, Rosenblatt A, Habot-Wilner Z. High-resolution ultrasound biomicroscopy as an adjunctive diagnostic tool for anterior scleral inflammatory disease. Acta Ophthalmol. 2016 [acceso: 04/07/2018];94(6):e384-9. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.12995

9. Cuchacovich M, Solanes F, Pérez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F. Mycophenolate Mofetil Therapy in Refractory Inflammatory eye disease. J Ocul Pharmacol Ther. 2016 [acceso: 04/07/2018];32(1):55-61. Disponible en: http://repositorio.uchile.cl/bitstream/handle/2250/138478/Mycophenolate-Mofetil-Therapy-RESTRINGIDO.pdf?sequence=1

10. Sands DS, Chan SCY, Gottlieb CC. Methotrexate for the treatment of noninfectious scleritis. Can J Ophthalmol. 2018 [acceso: 24/10/2018];53(4):349-53. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30119788

11. Lawuyi LE, Gurbaxani A. Refractory necrotizing scleritis successfully treated with adalimumab. J Ophthalmic Inflammat Infect. 2016 [acceso: 04/07/2018];6:37. Disponible en: https://link.springer.com/article/10.1186/s12348-016-0107-y